- Drugs
- Wednesday, 06 May 2020
India will ship nearly 1,000 tonnes of paracetamol raw material to Europe
The Indian government in March put a hold on exports of several drugs including paracetamol to secure supplies for its people after the coronavirus outbreak disrupted the industry’s supply chain globally. COVID-19 is the respiratory disease caused by the novel coronavirus.
Europe has sought up to 800 tonnes of paracetamol APIs every month, said Dinesh Dua, chairman of the Pharmaceuticals Export Promotion Council of India (Pharmexcil).
“We have been under immense pressure from the European Union for the last 10 days,” Dua said.
The European Union delegation in India did not immediately reply to an email from Reuters requesting comment on the planned shipment.
Indian authorities have asked drugmakers to ensure the country is adequately stocked for up to four months of domestic requirements, Dua said.
India, the world’s main supplier of generic drugs, has shipped 1.9 million tablets and other forms of paracetamol to 31 countries, the foreign ministry said late last month, adding that consignments of anti-malaria drug hydroxychloroquine and paracetamol were being sent to 87 countries on a commercial basis.
Europe is India’s biggest buyer of paracetamol APIs and imports around 12,000 tonnes annually, according to Pharmexcil estimates. The common pain reliever is also sold as acetaminophen.
The novel coronavirus outbreak has killed more than a quarter of a million people and Europe has accounted for 57% of the global death toll.
India has so far reported more than 49,000 cases of COVID-19. The outbreak has not shown any signs of slowing despite a severe lockdown that has confined its population of 1.3 billion to their homes since late March.
Related Industry Updates
Vitamin K2 Market is expected to reach US$ 11,60,779.02 Thousands by 2030
Oct 11, 2023
North America Antibiotics Market is Estimated to Grow with a CAGR of 3.9% from 2020 to 2027
Sep 24, 2020
US Mail Order Pharmacy Market is expected to reach US$ 1,71,883.03 million by 2030
Oct 16, 2023
Idiopathic Pulmonary Fibrosis Treatment Market is expected to reach US$ 10,784.07 million by 2030
Dec 12, 2023
DisposeRx Adds New Community Outreach Partners to Stop Prescription Drug Abuse
Jun 10, 2020
Hikma launches Dicyclomine Hydrochloride Oral Solution
May 28, 2020
Aphria Inc.'s Jamaican Subsidiary, Marigold, Receives Retail Herb House Licence
Sep 17, 2019